Guardant Health released test results showing its blood test accurately detected colorectal cancer or precancer 83% of the time.
Dec 16, 2022, 4:32pm PST
The results indicate Guardant's test won't be an adequate substitute for colonoscopies or Cologuard, a screening that looks for signs of cancer in patients' stool, Jeffries analyst Brandon Couillard told Bloomberg. Cologuard maker Exact Sciences Inc. says its test is 92% accurate at detecting colon cancer., down $11.20 a piece. Earlier in the session, its shares were down as much as $13.51, or 32%.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Guardant Health stock plunges, Exact Sciences stock soars after colorectal-cancer test study resultsShares of Guardant Health Inc. undefined tanked 40% and shares of Exact Sciences Corp. undefined rallied more than 25% in the extended session Thursday after...
Read more »
27 Video Games We Played And Loved In 2022 That You Also Need To Play ASAP2022 was a great year for games, folks.
Read more »
Unbanked.com Launches Cryptocurrency Card in UK and Europe Сovering 27 СountriesFintech major Unbanked Inc., together with Moorwand, releases cryptocurrency card for B2C users
Read more »
This 27-Inch Digital Art Frame Is Actually an LG Air ConditionerThe perfect solution for a home that looks, and feels, cool.
Read more »
Wool Emporium closing after 27 years of uniting fibre enthusiasts\u0022I\u0027ve appreciated all of the support and all of the friendships that we\u0027ve made over the years.\u0022
Read more »
I saw LG's 27-inch OLED, the future of gaming monitors | Digital TrendsThe LG 27-inch UltraGear OLED QHD is an impressive display with market-first features including a 240Hz refresh rate and 0.03 response time GtG response time.
Read more »